Pfizer Director Mortimer J. Buckley Acquires Phantom Stock Units via Deferred Compensation
PFIZER INC
Subscribe to track PFE
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
=== SEC FORM 4: PFIZER INC (PFE) ===
Insider: Buckley Mortimer J
Role: Director
Date: 2026-09-25
Type: Acquisition (Award/Grant)
Security: Phantom Stock Units
Shares: 1,307.987
Price: $28.67
Value: $37,499.99
Holdings: 28,039.756
Significance: Low (Routine Director Deferred Compensation)
Comprehensive Analysis
Transaction Overview
On September 25, 2026, Mortimer J. Buckley, a member of the Board of Directors of Pfizer Inc. (NYSE: PFE), acquired approximately 1,307.99 phantom stock units valued at $28.67 per share, totaling approximately $37,500. Following this grant, Buckley directly holds 28,039.76 phantom stock units.
Transaction Nature
The transaction was reported under Transaction Code A (Grant, award or other acquisition pursuant to Rule 16b-3). Per the footnotes, these phantom stock units represent deferred director's compensation (including dividend equivalents) payable in cash or common stock upon retirement from the Board.
Market & Trading Significance
This transaction reflects routine, scheduled equity-based compensation for non-employee directors rather than discretionary open-market buying. As an automated deferred compensation credit, it carries Low informational or market-predictive value.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.